Table 1. Comparability of intradermally and subcutaneously vaccinated groups.
| Participants | Vaccine administration | p-value | ||
| Intradermal | Subcutaneous | |||
| Primovaccinees (N = 155) | N Female (%) | 56 (73) | 65 (83) | 0·1 |
| Mean age (range) | 27 (18–61) | 25 (19–70) | 0·2 | |
| Flavivirus$ N yes (%) | 33 (43) | 26 (33) | 0·3 | |
| Revaccinees (N = 20) | N Female (%) | 7 (70) | 8 (80) | - |
| Mean age (range) | 30 (20–50) | 34 (21–48) | 0·4 | |
Age and gender distribution in primary (77 i.d., 78 s.c.) and booster (10 i.d., 10 s.c.) vaccinated populations. YF-17D = yellow fever vaccine virus.
$
Flavivirus = possible flavivirus encounter in past five years defined as travelled to flavivirus endemic destination.